NeOnc Technologies Holdings is trading 11.23% down at $4.15 in pre-market, based on the provided pre-market quote, with no clear company-specific catalyst identified.

  • No clear August 24, 2026 company-specific catalyst was identified.
  • The latest major announcement was positive Phase 2a NEO100 data on August 12, including 86.7% six-month overall survival.
  • Recent coverage cited insider purchases on August 18; broader Nasdaq weakness may add pressure, but the decline remains unexplained.